نتایج جستجو برای: hbsag

تعداد نتایج: 5038  

Journal: :The Korean Journal of Internal Medicine 2007
Soon Woo Nam Jeong Jo Jung Si Hyun Bae Jong Young Choi Seung Kew Yoon Se Hyun Cho Joon Yeol Han Nam Ik Han Jin Mo Yang Young Suk Lee

BACKGROUND Spontaneous delayed clearance of hepatitis B surface antigen (HBsAg) in patients with chronic HBV infection is a rare event. The aim of this study was to investigate the incidence of delayed clearance of serum HBsAg in chronic HBV infection and to determine the characteristics and clinical outcomes of HBsAg delayed clearance in Korean patients. METHODS From April 1981 to June 2003,...

Journal: :The Journal of infectious diseases 2015
Arjan Boltjes Nadine van Montfoort Paula J Biesta Marjoleine L Op den Brouw Jaap Kwekkeboom Luc J W van der Laan Harry L A Janssen André Boonstra Andrea M Woltman

BACKGROUND Based on their localization, Kupffer cells (KCs) likely interact with hepatitis B virus (HBV). However, the role of KCs in inducing immunity toward HBV is poorly understood. Therefore, the interaction of hepatitis B surface antigen (HBsAg) and KCs, and possible functional consequences, were assessed. METHODS KCs in liver tissue from patients with chronic HBV were analyzed for prese...

2016
Yih-Lin Chung Mei-Ling Wu

Proteasome-mediated degradation of promyelocytic leukemia tumor suppressor (PML) is upregulated in many viral infections and cancers. We previously showed that PML knockdown promotes early-onset hepatocellular carcinoma (HCC) in hepatitis B virus surface antigen (HBsAg)-transgenic mice. Here we report the effects of PML restoration on late-onset HBsAg-induced HCC. We compared protein expression...

Journal: :Antiviral therapy 2012
Milan J Sonneveld Vincent Rijckborst Yilmaz Cakaloglu Krzysztof Simon E Jenny Heathcote Fehmi Tabak Tomasz Mach Charles A B Boucher Bettina E Hansen Stefan Zeuzem Harry L A Janssen

BACKGROUND On-treatment decline of serum hepatitis B surface antigen (HBsAg) may reflect the immunomodulatory effect of pegylated interferon (PEG-IFN) for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB). We compared HBsAg decline across HBV genotypes between combined responders (HBeAg loss and HBV DNA<10,000 copies/ml at week 78), HBeAg responders (HBeAg loss with HBV DNA>10,00...

2018
Tien-Ching Lin Yen-Cheng Chiu Hung-Chih Chiu Wen-Chun Liu Pin-Nan Cheng Chiung-Yu Chen Ting-Tsung Chang I-Chin Wu

AIM To investigate the utility of hepatitis B surface antigen (HBsAg) kinetics in chronic hepatitis B patients during long-term entecavir treatment. METHODS This retrospective study included treatment-naïve chronic hepatitis B patients who received at least 2 years of consecutive entecavir treatment. Patients were followed up at three to six month intervals with liver biochemistry, hepatitis ...

2017
Romina Salpini Matteo Surdo Nadia Warner Maria Francesca Cortese Danny Colledge Sally Soppe Maria Concetta Bellocchi Daniele Armenia Luca Carioti Fabio Continenza Domenico Di Carlo Patrizia Saccomandi Carmen Mirabelli Michela Pollicita Roberta Longo Sara Romano Giuseppina Cappiello Alberto Spanò Pascale Trimoulet Herve Fleury Jacopo Vecchiet Nerio Iapadre Angelo Barlattani Ada Bertoli Terenzio Mari Caterina Pasquazzi Gabriele Missale Cesare Sarrecchia Elisa Orecchini Alessandro Michienzi Massimo Andreoni Simona Francioso Mario Angelico Jens Verheyen Francesca Ceccherini-Silberstein Stephen Locarnini Carlo Federico Perno Valentina Svicher

BACKGROUND An impaired HBsAg-secretion can increase HBV oncogenic-properties. Here, we investigate genetic-determinants in HBsAg correlated with HBV-induced hepatocellular carcinoma (HCC), and their impact on HBsAg-secretion and cell-proliferation. METHODS This study included 128 chronically HBV-infected patients: 23 with HCC (73.9% D; 26.1% A HBV-genotype), and 105 without cirrhosis/HCC (72....

Journal: :International journal of epidemiology 2002
Ming-Whei Yu Hung-Chuen Chang Pei-Jer Chen Chun-Jen Liu Yun-Fan Liaw Shi-Ming Lin Shou-Dong Lee Shee-Chan Lin Chih-Lin Lin Chien-Jen Chen

BACKGROUND There is a tendency for familial aggregation of hepatocellular carcinoma (HCC). The aims of this study were to assess the degree to which familial aggregation of hepatitis B surface antigen (HBsAg) carriers accounts for familiality of HCC in families of hepatitis B-related HCC patients, and whether HCC shares a familial predisposition with liver cirrhosis among HBsAg carriers. METH...

Journal: :Journal of clinical microbiology 1975
R I Ramirez M L Tiku P L Ogra

A recently described hemagglutination test for hepatitis B antigen (HBsAg) using turkey erythrocytes coated with horse antibody to HBsAg purified by affinity column chromatography was evaluated on a comparative basis with 100 HBsAg-positive and -negative serum samples. The turkey erythrocyte hemagglutination test (TEHA) was found to be less sensitive than radioimmunoassay (RIA) but gave far bet...

Journal: :Intervirology 2010
E Veropalumbo A Marrone L Vallefuoco G Perruolo R Orlando F Scordino G Tosone R Zampino B Trani A Genovese G Spadaro C D'Orio G Portella

Hepatitis B surface antigen (HBsAg) is considered the best marker for the diagnosis of hepatitis B virus (HBV) infection. Mutations of the s gene involving amino acid substitutions within the a determinant could affect the sensitivity of diagnostic tests. In the present study, HBsAg mutants were detected in 3 immunocompromised patients, previously found to be HBsAg negative and anti-HBs positiv...

Journal: :Clinical chemistry 2006
Dan Chen Lawrence A Kaplan

BACKGROUND The usual criteria for analysis of hepatitis B surface antigen (HBsAg) are detection of HBsAg and result confirmation by antibody neutralization. We observed that with the Immulite 2000 HBsAg assay [Diagnostics Product Corporation (DPC)] a relatively high percentage of weakly reactive (WR) samples did not pass the neutralization step. METHODS For each of 3 lots of Immulite 2000 HBs...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید